Logo
M

Massive Bio

56 employees

Massive Bio is an AI powered oncology platform that connects patients to clinical trials while enabling pharma to get access to patients.

Basic info

Industry

hospital & health care

Sectors

Biotechnology
Cancer Treatment
Pharmaceutical
Artificial Intelligence
Targeted cancer therapies
Tumor profiling technologies
Oncology
Health Care
Big Data
Cancer Care
precision oncology
Cancer Research
Clinical Trials
Second Opinion
Therapeutics
Natural Language Processing
personalized cancer treatment options
Medical
Machine Learning
Cancer genomics
Clinical trial selection

Date founded

2014

Funding rounds raised

Total raised

$17M

from 7 investors over 7 rounds

M

Massive Bio raised $17M on June 2, 2022

Investors: Revo Capital, SiteGround Web Hosting Company, IFC Asset Management Company (AMC) and ImpactAssets

M

Massive Bio raised $2.8M on November 3, 2020

Investors: Revo Capital

M

Massive Bio raised $2M on May 2, 2019

Investors: International Private Bank

M

Massive Bio raised undisclosed on April 3, 2015

Investors: 500 Startups

FAQ